Misoprostol linked to deaths with off-label use

At least eight women have died from shock complications of an acute Clostridial infection following a medical abortion using a combination of mifepristone (Mifeprex) and misoprostol (Cytotec).

A new animal trial linked misopristol, the abortion drug used orally in combination with RU-486, to fatal infections in seven of the women. These seven women used the drug as a vaginal suppository, rather than as an oral agent. The drug has been deemed safe when given orally, but its off-label use might cause immune system suppression that allows a certain bacterium to achieve deadly virulence.

According to Arnoff, "When the drug is given orally, it does not appear to have a suppressive effect on reproductive tract immunology." However, "If the drug is applied directly to the reproductive tract, that's where we can see suppression of the immune system." The study appears in the online version of the Journal of Immunology. The researchers found that misoprostol--when used off-label--dramatically increased the virulence and lethality of the bacteria by about 50-fold.

- see the story on Med Page Today
- read the Journal of Immunology study abstract

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.